The development of cardio-oncology as a clinical field has been driven by improved therapeutics resulting in a dramatic increase in the number of cancer survivors (~17,000,00 in the United States alone) many of whom suffer cardiovascular complications related to their cancer treatments. Both "traditional" and "targeted" therapies can affect the cardiovascular system resulting in hypertension, heart failure, myocarditis, arrhythmias, vascular disease, and thrombosis. While recurrence of cancer is the eventual cause of death in many "cancer survivors", cardiovascular disease is responsible for substantial morbidity and mortality in this population. Thus, effective means of mitigating cardiovascular complications of cancer therapies would have substantial impact on health. Here we will review novel issues in cardio-oncology and will give a broad overview of this emerging field.

National lipid expert faculty will discuss the incidence of and diagnostic criteria for statin intolerance, explain the mechanistic rationale for lowering LDL-C through nonstatin therapies, explore novel targets and treatment pathways, and apply the 2018 AHA/ACC Cardiology Cholesterol Guidelines. Learners will have gain practical clinical perspectives during expert case study discussions, including how new treatment options may fit into the current therapeutic landscape.

A case of a woman with early symptoms of joint pains is presented and discussed as to what clinical, laboratory, imaging, and physical features will guide us to identify and distinguish between RA, psoriatic arthritis, SLE, and fibromyalgia. The key historical and clinical findings that distinguish these diseases are presented and the proper interpretation of imaging and tests like the ANA are reviewed.

Hypercholesteremia is highly prevalent in the U.S. and strongly associated with cardiovascular morbidity and mortality. Yet, only about 55% of U.S. adults appropriate for cholesterol lowering therapy are currently taking it. What do primary care providers need to know to improve the care of the many individuals with hypercholesterolemia that you see daily in clinical practice? Join Dr. Ty Gluckman for part 2 of this webcast series to find out.

Dr. Lamas will examine the thin border between life and death through real stories of patients whose lives were saved by modern medical technology. Her talk will also touch on the long-term consequence of survival faced by many coronavirus patients.

Practice-changing updates to the medical literature that are hot off the presses! Join Dr. Pam Kushner to discuss important changes in the 2021 ADA guidelines and examine recently published research on atrial fibrillation, lipids, reducing cardiovascular risk, coconut oil, patient communication, and much more!

In the twenty-first episode of Pri-Med’s web series on COVID-19, faculty will provide some insight into a newly relevant COVID-19 treatment; monoclonal antibodies. Current events have shown a light on monoclonal antibodies and faculty will distinguish this treatment from convalescent plasma and hyperimmune globulin, as well as explain how it is made and might work against COVID-19. The second topic of this webcast will focus on mental health its status as we approach a year into a pandemic. Faculty will also discuss some recent data on the impact that mindfulness programs might have as an intervention to improve mental health.

Heart failure is a global pandemic that continues to increase in prevalence. Despite the availability of established and novel therapies, mortality and morbidity in heart failure remains high. Join us for this overview of heart failure classification and pathophysiology, the evidence base supporting various treatments, and current guideline recommendations. Despite being the most common sustained arrhythmia in practice, the ideal management strategy for atrial fibrillation remains elusive for many clinicians. Accordingly, this session will review the classification and initial workup of patients with atrial fibrillation, with further discussion of the primary treatment goals. Stroke prevention therapies will be reviewed, along with means to achieve rate and rhythm control. Tune in to learn about ongoing gaps in the care of patients with heart failure and/or atrial fibrillation and how a standardized approach can help improve outcomes.

Review practice-changing articles from 2020! During this informative session on medical literature updates (excluding COVID-19), primary care physician, Dr. Charles Vega, will review the clinical implications of practice-changing literature that has been recently published. Topics for discussion will include: HPV vaccination, mammography, colorectal cancer screening, osteoporosis, coconut oil, milk and weight gain, mask efficacy, COPD exacerbations, medication-assisted treatment for opioid disorder and more! You don’t want to miss these important updates!

The COVID-19 pandemic has disproportionally impacted the African American community. How can you help care for your patients during these stressful times? This session will provide an overview of the health disparities related to the COVID-19 pandemic as well as the stress that many patients are feeling. We will look at the demographics of mental illnesses across race/ethnicities as well as look at perspectives on the differences noted. Lastly, we will discuss approaches to pain management difficulties in patients based on recent research outcomes.

What do primary care providers need to know about migraine, movement disorders, dizziness, and vertigo? Join neurologists Patricia Greenstein, Daniel Press, and Rashmi Halker Singh as they review important questions they get asked about these topics!